tirzepatide from eli lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly sues companies selling

Lets look at what the science is saying, so you can make an informed decision on whether you should incorporate GLP-1 injections into your health plans

Eden earns a perfect score in transparency

Absolute risk reduction: 1.3% Death from CV causes occurred in fewer patients in the Victoza group (219 patients [4.7%]) than in the SOC group (278 [6.0%]) (hazard ratio, 0.78

In a similar model of LDLr-/- mice, alogliptin (30 mg/kg/d for 7 weeks) reduced the collagen-1 mRNA expression and triglyceride levels in hepatic cells

Current evidence suggests PT-141 is safe for ongoing as-needed use when administered appropriately

Accessed 28 July 2021